Skip to content

Efficacy of Triphaladi churna (orally) along with Mustadi rasakriya anjan and Triphaladi churna (orally) alone in the management of Dry type of age related macular degeneration

Efficacy of Triphaladi churna (orally) along with Mustadi rasakriya anjan and Triphaladi churna (orally) alone in the management of Dry type of age related macular degeneration - An open labelled randomized comparative clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042658
Enrollment
30
Registered
2022-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole

Interventions

None listed

Sponsors

Government Akhandanand Ayurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 40-90 years of either sex. 2. visual acuity for distance vision between 6/6 to 6/60 and for near vision N/6 to N/36 with glasses. 3. The patient presenting with signs and symptoms of ARMD (DRY TYPE) like Difficulty in day vision, Diminished vision, Distorted vision, Perception of black spots in the field of vision, Perception of flashes of light, Problem for adaptation with dim light, presence of macular drusens , focal hyperpigmentation , pale area of retinal pigment atrophy in retina will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Age less than 40 years and more than 90 years. 2. visual acuity for distance vision less than 6/60 and for near vision more than N/36 with glasses 3. Contraindicated for Anjan Sama Avastha of Netra (Doshas associated with aam) ,Ghana Pichchila Srava ( Thick/dense , sliminess discharge ), Ati Kandu ( Excessive itching ),Swayathu ( Swelling ),Mlan Netrata (Tired eye) SYSTAMIC EXCLUSION: Chronic debilitating diseases like Renal disorder, Liver disorder, Hiv, Carcinoma . OPHTHALMIC EXCLUSION: Wet type of ARMD, Glaucoma ,Mature cataract ,Pan retinal degenerations ,Chronic conjunctivitis ,Keratoconjunctivitis ,Hypertensive retinopathy ,Diabetic retinopathy , Any type of ocular injury e.g. blunt trauma, including chemical injury

Design outcomes

Primary

MeasureTime frame
To reduce difficulty in vision, dimnished vision and distored vision in ARMD patientsTimepoint: 58 days

Secondary

MeasureTime frame
To improve quality of life with the improve vision.Timepoint: 88 days

Countries

India

Contacts

Public ContactVd Hemangi B Shukla

Government akhandanad ayurveda college

drhemangishukla@gmail.com9825504280

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026